Skip to main content

Published locations for ADA: Alefacept slows progress of type 1 diabetes 15 months post-treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ADA: Alefacept slows progress of type 1 diabetes 15 months post-treatment

User login

  • Reset your password
  • /content/ada-alefacept-slows-progress-type-1-diabetes-15-months-post-treatment
  • /familypracticenews/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months
  • /internalmedicinenews/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months
  • /pediatricnews/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months-post
  • /clinicalendocrinologynews/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15
  • /pediatrics/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months-post
  • /endocrinology/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months-post
  • /internalmedicine/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months-post
  • /familymedicine/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months-post
  • /type-2-diabetes-icymi/article/101103/diabetes/ada-alefacept-slows-progress-type-1-diabetes-15-months